Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 1, keine Gesamtzahl für „IRRs“
Suchtreffer
Begriffe & Kennungen
Adcetris · 4.8 · IRRs, such as headache, rash, back pain, vomiting, chills, nausea, dyspnoea, pruritus and cough were reported
Eintrag öffnenAdcetris · 4.8 · In clinical trials (C25003 [ADCETRIS + AVD] and SGN35-014 [ADCETRIS + CHP]), IRRs, such as headache, rash, bac
Eintrag öffnenBlitzima · 4.8 · IRRs may occur as a result of hypersensitivity and/or to the mechanism of action. 6 Includes observations coll
Eintrag öffnenBlitzima · 4.8 · In PV Study 2, IRRs occurred primarily at the first infusion and the frequency of IRRs decreased with subseque
Eintrag öffnenBlitzima · 4.8 · In the clinical trial in paediatric patients with GPA or MPA, the reported IRRs were predominantly seen with t
Eintrag öffnenBlitzima · 4.8 · Infusion-related reactions In GPA/MPA Study 1 (adult induction of remission study), IRRs were defined as any a
Eintrag öffnenBlitzima · 4.8 · The most frequent adverse reactions considered due to receipt of rituximab were IRRs. The overall incidence of
Eintrag öffnenBlitzima · 4.8 · The most frequently observed adverse reactions in patients receiving rituximab were IRRs which occurred in the
Eintrag öffnenBlitzima · 4.8 · The most frequently reported or observed serious adverse reactions were: IRRs (including cytokine-release sy
Eintrag öffnenBriumvi · 4.8 · The most important and frequently reported adverse reactions are IRRs (45.3%) and infections (55.8%).
Eintrag öffnenDarzalex · 4.8 · Infusion-related reactions (IRRs) In clinical studies (monotherapy and combination treatments; N=1573) with DA
Eintrag öffnenDarzalex · 4.8 · Infusion-related reactions (IRRs) In clinical studies (monotherapy and combination treatments; N=2066) the inc
Eintrag öffnenDarzalex · 4.8 · The most frequent adverse reactions of any grade (≥ 20% patients) were IRRs, fatigue, nausea, diarrhoea, const
Eintrag öffnenElfabrio · 4.8 · Infusion related reactions (adverse reactions within 2 hours of infusion) IRRs were reported in a total of 36
Eintrag öffnenEmpliciti · 4.8 · IRRs In the clinical trials of patients with multiple myeloma IRRs were reported in approximately 10% of preme
Eintrag öffnenEmpliciti · 4.8 · The most common adverse reactions (occurring in > 10% of patients) with elotuzumab treatment were IRRs, diarrh
Eintrag öffnenEnspryng · 4.8 · IRRs reported in patients treated with satralizumab were predominantly mild to moderate, and most occurred wit
Eintrag öffnenEnspryng · 4.8 · Injection-related reactions (IRRs)
Eintrag öffnenGazyvaro · 4.8 · Grade 3-4 IRRs occurred in 12% of patients. In Cycle 1, the overall incidence of IRRs was higher in patients r
Eintrag öffnenGazyvaro · 4.8 · IRRs were reported in 13.5% of patients in the Gazyvaro arm vs 10.4% of patients in the placebo arm. IRRs in b
Eintrag öffnen